Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 73551-73600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05687526
A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus
PHASE1Recruiting
12 participants
Started: May 25, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor12 locations
NCT05996783
Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial
NAActive, not recruiting
48,000 participants
Started: May 25, 2023 · Completed: Sep 30, 2026
4 conditions4 sponsors1 location
NCT05939661
A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer
PHASE2Recruiting
45 participants
Started: May 25, 2023 · Completed: Mar 31, 2030
1 condition1 sponsor2 locations
NCT05679284
A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs
N/ARecruiting
100 participants
Started: May 25, 2023 · Completed: Nov 15, 2028
5 conditions3 sponsors1 location
NCT05829421
Addressing Problems in Managing Daily Tasks Due to Poststroke Cognitive Impairments
NARecruiting
7 participants
Started: May 25, 2023 · Completed: Dec 2, 2025
2 conditions5 sponsors4 locations
NCT05873439
Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC
EARLY_PHASE1Active, not recruiting
3 participants
Started: May 25, 2023 · Completed: Oct 31, 2026
4 conditions1 sponsor1 location
NCT05889143
A Study to Evaluate the Efficacy and Safety of CREZET Tablet
N/AActive, not recruiting
15,000 participants
Started: May 24, 2023 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT06346106
The Diagnostic Experience of Male Rett Syndrome
N/ARecruiting
80 participants
Started: May 24, 2023 · Completed: Apr 30, 2024
2 conditions7 sponsors1 location
NCT06143423
A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.
PHASE1Recruiting
74 participants
Started: May 24, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05122767
Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)
PHASE1/PHASE2Recruiting
92 participants
Started: May 24, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT05673304
Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer
NARecruiting
30 participants
Started: May 24, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT04119908
Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
NARecruiting
400 participants
Started: May 24, 2023 · Completed: May 24, 2028
2 conditions1 sponsor1 location
NCT05865028
A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia
PHASE2Recruiting
32 participants
Started: May 24, 2023 · Completed: May 24, 2028
3 conditions2 sponsors1 location
NCT05473520
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
PHASE3Recruiting
150 participants
Started: May 24, 2023 · Completed: Jan 31, 2030
3 conditions7 sponsors6 locations
NCT05810870
PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin
PHASE2Recruiting
14 participants
Started: May 24, 2023 · Completed: Jul 31, 2027
3 conditions2 sponsors13 locations
NCT05398484
Psilocybin Therapy in Advanced Cancer
PHASE2/PHASE3Recruiting
300 participants
Started: May 24, 2023 · Completed: Jan 1, 2027
1 condition2 sponsors2 locations
NCT05648591
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
PHASE4Recruiting
100 participants
Started: May 24, 2023 · Completed: Nov 30, 2026
2 conditions1 sponsor9 locations
NCT05942287
The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction.
NARecruiting
110 participants
Started: May 24, 2023 · Completed: Dec 31, 2026
4 conditions2 sponsors2 locations
NCT05605509
RP-6306 in Patients With Advanced Cancer
PHASE2Active, not recruiting
28 participants
Started: May 24, 2023 · Completed: May 31, 2026
1 condition2 sponsors6 locations
NCT05870020
Validation of a Quality of Life Assessment Tool in Adult Generalized Dystonodyskinetic Syndromes Treated by Continuous Electrical Neuromodulation
NARecruiting
146 participants
Started: May 24, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06863870
Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma
N/AActive, not recruiting
35 participants
Started: May 24, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05713695
Supporting Treatment Access and Recovery Through Linkage and Support
NARecruiting
208 participants
Started: May 24, 2023 · Completed: Sep 30, 2026
2 conditions4 sponsors1 location
NCT06894095
Dongzong Cardiovascular Bio-imaging Registry Study
N/ARecruiting
50,000 participants
Started: May 24, 2023 · Completed: May 31, 2038
4 conditions1 sponsor1 location
NCT06256718
Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care
NARecruiting
560 participants
Started: May 24, 2023 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT05555485
Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
NARecruiting
60 participants
Started: May 24, 2023 · Completed: Sep 30, 2027
2 conditions3 sponsors1 location
NCT05215587
Scandinavian Trial of Uncomplicated Aortic Dissection Therapy
NARecruiting
554 participants
Started: May 24, 2023 · Completed: Dec 31, 2030
1 condition3 sponsors28 locations
NCT05080556
Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer
PHASE2Recruiting
80 participants
Started: May 24, 2023 · Completed: Nov 1, 2027
7 conditions4 sponsors1 location
NCT05404139
Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
PHASE2Recruiting
132 participants
Started: May 24, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors2 locations
NCT06593145
CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms
PHASE1Recruiting
6 participants
Started: May 24, 2023 · Completed: Jun 30, 2025
3 conditions1 sponsor2 locations
NCT05856318
Cardiometabolic Health in First Time Pregnancy
N/ARecruiting
3,500 participants
Started: May 24, 2023 · Completed: Dec 31, 2052
5 conditions9 sponsors7 locations
NCT05861245
Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
NARecruiting
20 participants
Started: May 24, 2023 · Completed: May 24, 2033
2 conditions1 sponsor1 location
NCT03826524
Epinephrine Dose: Optimal Versus Standard Evaluation Trial
PHASE4Recruiting
3,790 participants
Started: May 24, 2023 · Completed: Jun 30, 2028
4 conditions3 sponsors3 locations
NCT06148298
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
N/ARecruiting
24 participants
Started: May 24, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05390853
Active tDCS Versus Sham tDCS for Upper Limb Recovery in Incomplete Tetraplegic Patients
NARecruiting
30 participants
Started: May 24, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05600686
Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma
PHASE2Recruiting
24 participants
Started: May 24, 2023 · Completed: Feb 1, 2028
4 conditions3 sponsors1 location
NCT06227780
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
NARecruiting
180 participants
Started: May 24, 2023 · Completed: May 24, 2028
4 conditions2 sponsors1 location
NCT05840198
LH Canine Therapy Study
NARecruiting
48 participants
Started: May 24, 2023 · Completed: Dec 31, 2025
3 conditions2 sponsors2 locations
NCT05888597
Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease
PHASE2Recruiting
20 participants
Started: May 24, 2023 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT05722340
NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases
NARecruiting
24 participants
Started: May 24, 2023 · Completed: Nov 24, 2026
1 condition2 sponsors1 location
NCT05721404
Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis
PHASE4Recruiting
194 participants
Started: May 24, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05842811
An Observational Study of Patients With Metabolic Syndrome and Related Conditions
N/ANot yet recruiting
2,000,000 participants
Started: May 24, 2023 · Completed: Dec 31, 2038
1 condition1 sponsor0 locations
NCT06697535
A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)
PHASE2Recruiting
35 participants
Started: May 24, 2023 · Completed: Jul 30, 2026
1 condition1 sponsor1 location
NCT05907980
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
PHASE1Recruiting
219 participants
Started: May 24, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT05559736
Artemis Proximal Femoral Nail for Internal Fixation of Intertrochanteric Femur Fractures
NARecruiting
20 participants
Started: May 24, 2023 · Completed: Jun 30, 2026
3 conditions2 sponsors1 location
NCT05895383
Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy
PHASE4Recruiting
35 participants
Started: May 24, 2023 · Completed: Jan 30, 2025
3 conditions1 sponsor1 location
NCT05758480
Characterization of the Immunometabolic Signature in Long COVID-19.
NAActive, not recruiting
100 participants
Started: May 24, 2023 · Completed: Nov 3, 2025
1 condition1 sponsor1 location
NCT05299125
Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations
PHASE2Active, not recruiting
54 participants
Started: May 24, 2023 · Completed: Jul 31, 2027
1 condition2 sponsors14 locations
NCT04086082
Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging
NARecruiting
30 participants
Started: May 24, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05890183
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
NARecruiting
100 participants
Started: May 23, 2023 · Completed: May 31, 2028
3 conditions2 sponsors1 location
NCT05879419
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
PHASE4Active, not recruiting
2,005 participants
Started: May 23, 2023 · Completed: Dec 1, 2027
11 conditions2 sponsors1 location